For Quick Alerts
For Daily Alerts

Ajanta Pharma tumbles nearly 6% on downgrade

By Religare

Shares of Ajanta Pharma fell nearly 6 per cent on Bombay Stock Exchange (BSE) after analyst downgraded the stock on high valuation.

According to Economic Times report, analyst has cited a negative technical setup on the counter for the selloff, expecting the stock to remain under pressure in the short term.

Reacting to the news, the shares of the company dropped 5.75 per cent in intra-day trade to Rs 1352.00 apiece on the BSE.


In a similar trend, shares of the company dipped 4.15 per cent to Rs 1,376.95 a piece on National Stock Exchange.

Meanwhile, the broader benchmark BSE Sensex was trading at 25,137.92, down 63.98 points, or 0.25 per cent, at 13:15 hours.

Story first published: Monday, September 7, 2015, 23:00 [IST]
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'


We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more